tiprankstipranks
Nuvasive (DE:NK8)
FRANKFURT:NK8

NuVasive (NK8) Technical Analysis

0 Followers

Summary of all the Indicators

Overall Consensus
Sell
7Bullish
4Neutral
11Bearish
Technical Analysis Consensus
Sell
2Bullish
4Neutral
4Bearish
Moving Average Consensus
Sell
5Bullish
0Neutral
7Bearish
Nuvasive’s (NK8) Moving Averages Convergence Divergence (MACD) indicator is -0.67, suggesting Nuvasive is a Sell.
Nuvasive’s (NK8) 20-Day exponential moving average is 36.86, while Nuvasive’s (NK8) share price is €36.8, making it a Sell.
Nuvasive’s (NK8) 50-Day exponential moving average is 38.57, while Nuvasive’s (NK8) share price is €36.8, making it a Sell.

NuVasive (NK8) Pivot Points

Apr 28, 2024, 11:23 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
36.53
36.67
36.73
36.87
36.93
37.07
37.13
Fibonacci
36.67
36.74
36.79
36.87
36.94
36.99
37.07
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

NuVasive (NK8) Moving Averages

Apr 28, 2024, 11:23 AM
Period
Simple
Exponential
MA5
36.80Buy
36.74Buy
MA10
36.44Buy
36.57Buy
MA20
35.97Buy
36.86Sell
MA50
39.41Sell
38.57Sell
MA100
40.91Sell
39.93Sell
MA200
40.69Sell
40.46Sell
Nuvasive’s (NK8) 10-Day exponential moving average is 36.57, while Nuvasive’s (NK8) share price is €36.8, making it a Buy.
Nuvasive’s (NK8) 100-Day exponential moving average is 39.93, while Nuvasive’s (NK8) share price is €36.8, making it a Sell.
Nuvasive’s (NK8) stock price is €36.8 and Nuvasive’s (NK8) 50-day simple moving average is 39.41, creating a Sell signal.
Nuvasive’s (NK8) stock price is €36.8 and Nuvasive’s (NK8) 100-day simple moving average is 40.91, creating a Sell signal.
Nuvasive’s (NK8) stock price is €36.8 and Nuvasive’s (NK8) 200-day simple moving average is 40.69, creating a Sell signal.

NuVasive (NK8) Technical Indicators

Apr 28, 2024, 11:23 AM
Name
Value
Implied Action
RSI (14)
44.98
Neutral
STOCH (9,6)
90.61
Sell
STOCHRSI (14)
90.91
Sell
MACD (12,26)
-0.67
Sell
ADX (14)
27.56
Neutral
Williams %R
-9.09
Sell
CCI (14)
92.62
Neutral
ATR (14)
0.44
-
Ultimate Oscillator
39.93
Neutral
ROC
5.75
Buy
Nuvasive’s (NK8) Relative Strength Index (RSI) is 44.98, creating a Neutral signal.
Nuvasive’s (NK8) Trend Strength Indicator (ADX) is 27.56, creating a Neutral signal.
Nuvasive’s (NK8) Commodity Channel Index (CCI) is 92.62, creating a Neutral signal.
Nuvasive’s (NK8) Price Rate of Change (ROC) is 5.75, creating a Buy signal.

FAQ

Is NK8 a Buy, Hold, or Sell?
Based on NK8’s technical indicators, NK8 is a Sell.
    What is NK8’s RSI (14)?
    NK8’s RSI (14) is 44.98, which suggests NK8 is a Neutral.
      What is NK8’s MACD?
      NK8’s MACD is -0.67, which suggests NK8 is a Sell.
        What is NK8’s 5-day moving average?
        NK8’s 5-day moving average is 36.80, which suggests NK8 is a Buy.
          What is NK8’s 20-day moving average?
          NK8 20-day moving average is 35.97, which suggests NK8 is a Buy.
            What is NK8’s 50-day moving average?
            NK8’s 50-day moving average is 39.41, which suggests NK8 is a Sell.
              What is NK8’s 200-day moving average?
              NK8’s 200-day moving average is 40.69, which suggests NK8 is a Sell.
                What is NK8’s Williams % R (14)?
                NK8’s Williams % R (14) is -9.09, which suggests NK8 is a Sell.
                  What is NK8’s CCI (14)?
                  NK8’s CCI (14) is 92.62, which suggests NK8 is a Neutral.
                    What is the share price of Nuvasive?
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis